Impact of Left Ventricular Assist Devices on the Quality of Life and Functional Outcomes in Advanced Heart Failure: A Comprehensive Review
- PMID: 40717888
- PMCID: PMC12296874
- DOI: 10.7759/cureus.88527
Impact of Left Ventricular Assist Devices on the Quality of Life and Functional Outcomes in Advanced Heart Failure: A Comprehensive Review
Abstract
Managing advanced heart failure (HF) remains a major clinical challenge, especially for patients who no longer respond to conventional treatment options, or are not candidates for heart transplantation. In such cases, left ventricular assist devices (LVADs) have become an important option, offering mechanical support that has the potential to extend life and improve daily functioning. With ongoing advancements in technology, there is growing interest in understanding how LVADs impact not just survival, but also patients' quality of life (QoL) and overall recovery. This narrative review explores the role of LVAD therapy in improving functional status and QoL in patients with advanced HF. It draws on clinical research from the past 15 years to examine physical, psychological, and social outcomes, as well as the challenges and complications associated with this treatment. A structured PubMed search was performed using predefined MeSH terms and keywords related to LVADs. After removing duplicates, 68 articles were identified. Eleven reviewers screened titles and abstracts, followed by full-text review and data extraction. Studies were included if they involved adults, were conducted in the past 15 years, and used clinical or observational study designs. Non-English, pediatric, and pregnancy-related studies were excluded. A total of 44 studies met the criteria. LVADs were associated with improvements in physical function, exercise capacity, and QoL. However, patients often faced psychological stress and medical complications. Better pre-implant health and strong support systems contributed to more favorable outcomes. LVADs offer meaningful improvements in both survival and QoL, but holistic, patient-centered care remains key to optimizing outcomes.
Keywords: 6 minute walk test; bridge to transplant; complications; destination therapy; functional recovery; heart failure; left ventricular assist device; lvad; psychological support; quality of life.
Copyright © 2025, Maaz Shah et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures



Similar articles
-
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450. Health Technol Assess. 2005. PMID: 16303098
-
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.Health Technol Assess. 2024 Aug;28(38):1-237. doi: 10.3310/MLFA4009. Health Technol Assess. 2024. PMID: 39189844 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530. Health Technol Assess. 2013. PMID: 24280231 Free PMC article.
-
Evaluation of the ventricular assist device programme in the UK.Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. doi: 10.3310/hta10480. Health Technol Assess. 2006. PMID: 17134596
References
-
- Global burden of heart failure and its underlying causes in 204 countries and territories, 1990-2021. Chen QF, Chen L, Katsouras CS, et al. https://doi.org/10.1093/ehjqcco/qcae110. Eur Heart J Qual Care Clin Outcomes. 2025;11:493–509. - PubMed
-
- Is there an association between living in a rural area and the incidence of postoperative complications or hospital readmissions following left ventricular assist device (LVAD) implantation, compared to urban LVAD recipients? A systematic review. Gollapudi S, Gollapudi A, Banala S, Singh S, Tadi K. https://doi.org/10.1002/clc.70068 Clin Cardiol. 2025;48:0. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous